784870004: Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor agonist (product)\Product containing muscarinic receptor agonist (product)\Product containing pilocarpine (medicinal product)\Pilocarpine-containing product in ocular dose form\Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor agonist (product)\Product containing muscarinic receptor agonist (product)\Product containing pilocarpine (medicinal product)\Product containing physostigmine and pilocarpine (medicinal product)\Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor agonist (product)\Product containing muscarinic receptor agonist (product)\Product containing pilocarpine (medicinal product)\Product containing physostigmine and pilocarpine (medicinal product)\Product containing only physostigmine and pilocarpine (medicinal product)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing physostigmine (medicinal product)\Product containing physostigmine in ocular dose form (medicinal product form)\Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing physostigmine (medicinal product)\Product containing physostigmine and pilocarpine (medicinal product)\Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing physostigmine (medicinal product)\Product containing physostigmine and pilocarpine (medicinal product)\Product containing only physostigmine and pilocarpine (medicinal product)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution

\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing carbamate (product)\Product containing physostigmine (medicinal product)\Product containing physostigmine in ocular dose form (medicinal product form)\Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing carbamate (product)\Product containing physostigmine (medicinal product)\Product containing physostigmine and pilocarpine (medicinal product)\Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing carbamate (product)\Product containing physostigmine (medicinal product)\Product containing physostigmine and pilocarpine (medicinal product)\Product containing only physostigmine and pilocarpine (medicinal product)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing azole (product)\Product containing imidazole (product)\Product containing pilocarpine (medicinal product)\Pilocarpine-containing product in ocular dose form\Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing azole (product)\Product containing imidazole (product)\Product containing pilocarpine (medicinal product)\Product containing physostigmine and pilocarpine (medicinal product)\Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing azole (product)\Product containing imidazole (product)\Product containing pilocarpine (medicinal product)\Product containing physostigmine and pilocarpine (medicinal product)\Product containing only physostigmine and pilocarpine (medicinal product)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution

\Medicinal product categorised by therapeutic role\Medicinal product acting as antiglaucoma agent (product)\...

\Pilocarpine-containing product in ocular dose form\Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution

\Product containing physostigmine in ocular dose form (medicinal product form)\Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution

\Product manufactured as ocular dose form (product)\Pilocarpine-containing product in ocular dose form\Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution
\Product manufactured as ocular dose form (product)\Product containing physostigmine in ocular dose form (medicinal product form)\Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution

\Product containing autonomic agent (product)\Parasympathomimetic agent-containing product\...

\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing physostigmine (medicinal product)\...

\Product containing physostigmine in ocular dose form (medicinal product form)\Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution

\Product containing physostigmine and pilocarpine (medicinal product)\Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution
\Product containing physostigmine and pilocarpine (medicinal product)\Product containing only physostigmine and pilocarpine (medicinal product)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution

\Product containing acetylcholine receptor agonist (product)\Product containing muscarinic receptor agonist (product)\Product containing pilocarpine (medicinal product)\...

\Pilocarpine-containing product in ocular dose form\Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution

\Product containing physostigmine and pilocarpine (medicinal product)\Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution
\Product containing physostigmine and pilocarpine (medicinal product)\Product containing only physostigmine and pilocarpine (medicinal product)\Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)\Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3765647017 Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3765648010 Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4527331000052112 fysostigminsalicylat 2,5 milligram/milliliter och pilokarpinhydroklorid 20 milligram/milliliter, lösning för oftalmiskt bruk sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution	Plays role	Antiglaucoma therapeutic role	true	Inferred relationship	Some
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution	räkning av bas i aktiv ingrediens	två	false	Inferred relationship	Some
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution	har nämnarvärde som visar koncentrationsstyrka	ett	false	Inferred relationship	Some	2
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	1
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution	har täljarvärde för koncentrationsstyrka	20	false	Inferred relationship	Some	1
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution	Has basis of strength substance (attribute)	Physostigmine salicylate	true	Inferred relationship	Some	2
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	2
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution	Has manufactured dose form	Conventional release eye solution (dose form)	true	Inferred relationship	Some
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution	Has precise active ingredient	Pilocarpine hydrochloride (substance)	true	Inferred relationship	Some	1
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	2
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	1
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution	Has precise active ingredient	Physostigmine salicylate	true	Inferred relationship	Some	2
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution	har täljarvärde för koncentrationsstyrka	2,5	false	Inferred relationship	Some	2
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution	Has basis of strength substance (attribute)	Pilocarpine hydrochloride (substance)	true	Inferred relationship	Some	1
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution	har nämnarvärde som visar koncentrationsstyrka	ett	false	Inferred relationship	Some	1
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution	Is a	Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)	true	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3765647017	Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3765648010	Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4527331000052112	fysostigminsalicylat 2,5 milligram/milliliter och pilokarpinhydroklorid 20 milligram/milliliter, lösning för oftalmiskt bruk	sv	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Sweden NRC maintained module (core metadata concept)